220
Participants
Start Date
July 7, 2003
Primary Completion Date
March 21, 2012
Study Completion Date
June 18, 2013
Cisplatin
80mg/m2 IV day 1
Radiotherapy
35 Gy in 15 fractions
5-Fluorouracil
800mg/m2/day IV days 1 - 4
Liverpool Hospital, Liverpool
Prince of Wales Hospital, Randwick
Royal North Shore Hospital, Sydney
Peter MacCallum - Box Hill Hospital, Box Hill
Peter MacCallum - Moorrabbin, East Bentleigh
Andrew Love Cancer Care Centre, Geelong Hospital, Geelong
Premion - Wesley, Auchenflower
Royal Brisbane Hospital, Herston
Radiation Oncology - Mater Centre, South Brisbane
Princess Alexandra Hospital, Woolloongabba
Christchurch Hospital, Christchurch
North Queensland Oncology Service, Townsville
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Launceston General Hospital, Launceston
Peter MacCallum Cancer Centre, Melbourne
Cross Cancer Centre, Edmonton
Cancer Care Manitoba Winnipeg, Winnipeg
Saint John Regional Hospital - Atlantic Health Sci, Saint John
Nova Scotia Cancer Centre, Halifax
Cancer Centre of Southeastern Ontario Kingston, Kingston
Grand River Cancer Centre, Kitchener
Princess Margaret Hospital, Toronto
Hotel-Dieu de Quebec, Québec
Princess Royal Hospital, Hull
National Health and Medical Research Council, Australia
OTHER
Canadian Cancer Trials Group
NETWORK
Trans Tasman Radiation Oncology Group
OTHER